Mohamad Aman Jairajpuri

Mohamad Aman Jairajpuri

Auto-generated profile, based on publicly available information

Mohamad Aman Jairajpuri

Department of Bioscience, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
TBTeena Bhakuni
Teena Bhakuni
MAMohammad Farhan Ali
Mohammad Farhan Ali
IAIrshad Ahmad
Irshad Ahmad
SBShadabi Bano
Shadabi Bano
SAShoyab Ansari
Shoyab Ansari
MJMohamad Aman Jairajpuri
Mohamad Aman Jairajpuri

23 October 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JRJia Rao
Jia Rao
SAShazia Ashraf
Shazia Ashraf
WTWeizhen Tan
Weizhen Tan
AVAmelie T. van der Ven
Amelie T. van der Ven
HGHeon Yung Gee
Heon Yung Gee
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
Steroid-resistant nephrotic syndrome (SRNS) is a frequent cause of chronic kidney disease. Here, we identified recessive mutations in the gene encoding the actin-binding protein advillin (AVIL) in 3 unrelated families with SRNS. While all AVIL mutations resulted in a marked loss of its actin-bundling ability, truncation of AVIL also disrupted colocalization with F-actin, thereby leading to impaired actin binding and severing. Additionally, AVIL colocalized and interacted with the phospholipase enzyme PLCE1 and with the ARP2/3 actin-modulating complex. Knockdown of AVIL in human podocytes reduced actin stress fibers at the cell periphery, prevented recruitment of PLCE1 to the ARP3-rich lamellipodia, blocked EGF-induced generation of diacylglycerol (DAG) by PLCE1, and attenuated the podocyte migration rate (PMR). These effects were reversed by overexpression of WT AVIL but not by overexpression of any of the 3 patient-derived AVIL mutants. The PMR was increased by overexpression of WT Avil or PLCE1, or by EGF stimulation; however, this increased PMR was ameliorated by inhibition of the ARP2/3 complex, indicating that ARP-dependent lamellipodia formation occurs downstream of AVIL and PLCE1 function. Together, these results delineate a comprehensive pathogenic axis of SRNS that integrates loss of AVIL function with alterations in the action of PLCE1, an established SRNS protein.

1 November 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
IAIrshad Ahmad
Irshad Ahmad
SSSwati Sharma
Swati Sharma
NGNeha Gupta
Neha Gupta
QRQudsia Rashid
Qudsia Rashid
MAMOHAMMAD ABID
MOHAMMAD ABID
MJMohamad Aman Jairajpuri
Mohamad Aman Jairajpuri

8 August 2014 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
QRQudsia Rashid
Qudsia Rashid
CKCharu Kapil
Charu Kapil
PSPoonam Singh
Poonam Singh
VKVineeta Kumari
Vineeta Kumari
MJMohamad Aman Jairajpuri
Mohamad Aman Jairajpuri
Serpins such as antithrombin, heparin cofactor II, plasminogen activator inhibitor, antitrypsin, antichymotrypsin, and neuroserpin are involved in important biological processes by inhibiting specific serine proteases. Initially, the protease recognizes the mobile reactive loop of the serpin eliciting conformational changes, where the cleaved loop together with the protease inserts into β-sheet A, translocating the protease to the opposite side of inhibitor leading to its inactivation. Serpin interaction with proteases is governed mainly by the reactive center loop residues (RCL). However, in some inhibitory serpins, exosite residues apart from RCL have been shown to confer protease specificity. Further, this forms the basis of multi-specificity of some serpins, but the residues and their dimension at interface in serpin-protease complexes remain elusive. Here, we present a comprehensive structural analysis of the serpin-protease interfaces using bio COmplexes COntact MAPS (COCOMAPS), PRotein Interface Conservation and Energetics (PRICE), and ProFace programs. We have carried out interface, burial, and evolutionary analysis of different serpin-protease complexes. Among the studied complexes, non-inhibitory serpins exhibit larger interface region with greater number of residue involvement as compared to the inhibitory serpins. On comparing the multi-specific serpins (antithrombin and antitrypsin), a difference in the interface area and residue number was observed, suggestive of a differential mechanism of action of these serpins in regulating their different target proteases. Further, detailed study of these multi-specific serpins listed few essential residues (common in all the complexes) and certain specificity (unique to each complex) determining residues at their interfaces. Structural mapping of interface residues suggested that individual patches with evolutionary conserved residues in specific serpins determine their specificity towards a particular protease.

28 March 2012 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
QRQudsia Rashid
Qudsia Rashid
PSPoonam Singh
Poonam Singh
MAMohammad Abid
Mohammad Abid
MJMohamad Aman Jairajpuri
Mohamad Aman Jairajpuri

26 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TBTeena Bhakuni
Teena Bhakuni
ASAmit Sharma
Amit Sharma
QRQudsia Rashid
Qudsia Rashid
CKCharu Kapil
Charu Kapil
RSRenu Saxena
Renu Saxena
MJMohamad Aman Jairajpuri
Mohamad Aman Jairajpuri
Antithrombin III (AT) is the main inhibitor of blood coagulation proteases like thrombin and factor Xa. In this study we report the identification and characterization of several variants of AT for the first time in Indian population. We screened 1950 deep vein thrombosis (DVT) patients for AT activity and antigen levels. DNA sequencing was further carried out in patients with low AT activity and/or antigen levels to identify variations in the AT gene. Two families, one with type I and the other with type II AT deficiency were identified. Three members of family I showed an increase in the coagulation rates and recurrent thrombosis in this family was solely attributed to the rs2227589 polymorphism. Four members of family II spanning two generations had normal antigen levels and decreased AT activity. A novel single nucleotide insertion, g.13362_13363insA in this family in addition to g.2603T>C (p.R47C) mutation were identified. AT purified from patient’s plasma on hi-trap heparin column showed a marked decrease in heparin affinity and thrombin inhibition rates. Western blot analysis showed the presence of aggregated AT. We also report a novel point mutation at position g.7549 A>G (p.T280A), that is highly conserved in serpin family. Variant protein isolated from patient plasma indicated loss of regulatory function due to in-vivo polymerization. In conclusion this is the first report of AT mutations in SERPINC1 gene in Indo-Aryan population where a novel point mutation p.T280A and a novel single nucleotide insertion g.13362_13363insA are reported in addition to known variants like p.R47C, p.C4-X and polymorphisms of rs2227598, PstI and DdeI.